<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01316510</url>
  </required_header>
  <id_info>
    <org_study_id>201018539</org_study_id>
    <nct_id>NCT01316510</nct_id>
  </id_info>
  <brief_title>Probiotics in Infants With Gastroschisis</brief_title>
  <official_title>Probiotics in Infants With Gastroschisis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infants born with gastroschisis usually require surgery shortly after birth. After surgery
      the intestine is often unable to digest human milk or formula for weeks or months. During
      this time the baby has to remain in the hospital to receive special nutrition through an IV.
      How bacteria colonize the intestine in these babies is unknown. Probiotics are bacteria that
      appear to have beneficial effects on digestion. This study will test whether giving probiotic
      bacteria to babies after surgery for gastroschisis will change the bacteria in the intestine
      to be more like those of a healthy breast-fed baby.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infants with gastroschisis have decreased intestinal motility. This decrease in intestinal
      motility delays the introduction and advancement of feeds which prolongs hospitalization. The
      use of probiotic bacteria may improve intestinal motility. It is unknown whether the
      intestinal microbiota of infants with gastroschisis differs from that of healthy infants
      without gastroschisis and whether probiotics will change the microbiota. The primary outcome
      in this study is the composition of the fecal microbiota in infants with gastroschisis
      following surgical correction treated with Bifidobacterium infantis or placebo. We will also
      look at differences in hospital length of stay.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composition of the fecal microbiota</measure>
    <time_frame>every two weeks for 6 weeks</time_frame>
    <description>Stools will be collected from messy diapers.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Initial discharge from the hospital</time_frame>
    <description>Number of days from surgery until discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Gastroschisis</condition>
  <arm_group>
    <arm_group_label>Bifidobacteria infantis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 billion organisms twice daily either through a feeding tube or by mouth for 6 weeks or until discharge (whichever happens first)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A dilute formulation of the elemental formula Nutramigen (diluted to look like the probiotic arm).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bifidobacteria infantis</intervention_name>
    <description>1 billion organisms twice daily either through a feeding tube or by mouth for 6 weeks or until discharge</description>
    <arm_group_label>Bifidobacteria infantis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Dilute Nutramigen formula</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gastroschisis

          -  Born at or transferred to UC Davis Children's hospital

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark A Underwood, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC Davis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark A Underwood, MD</last_name>
    <phone>762-7892</phone>
    <email>mark.underwood@ucdmc.ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robyn Borghese, MD</last_name>
    <phone>703-3050</phone>
    <email>robyn.borghese@ucdmc.ucdavis.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UC Davis Children's Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robyn Borghese, MD</last_name>
      <phone>916-703-3050</phone>
      <email>robyn.borghese@ucdmc.ucdavis.edu</email>
    </contact>
    <contact_backup>
      <last_name>Majid Mirmiran, MD, PhD</last_name>
      <phone>916-762-2780</phone>
      <email>majid.mirmiran@ucdmc.ucdavis.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Underwood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2011</study_first_submitted>
  <study_first_submitted_qc>March 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2011</study_first_posted>
  <last_update_submitted>January 22, 2015</last_update_submitted>
  <last_update_submitted_qc>January 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Probiotic</keyword>
  <keyword>bifidobacteria</keyword>
  <keyword>intestinal motility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroschisis</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>July 14, 2016</submitted>
    <returned>August 23, 2016</returned>
    <submitted>October 3, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

